m6A-centered Crosstalk Information
Mechanism of Crosstalk between m6A Modification and Epigenetic Regulation
| Crosstalk ID |
M6ACROT00091
|
[1], [2], [3], [4], [5] | |||
: m6A sites
Direct
Enhancement
RNA modification
AZIN1
AZIN1
ADAR
Methylation
: modification sites
|
|||||
| m6A Modification: | |||||
|---|---|---|---|---|---|
| m6A Regulator | Methyltransferase-like 3 (METTL3) | WRITER | |||
| m6A Target | Interferon-inducible protein 4 (ADAR1) | ||||
| Epigenetic Regulation that have Cross-talk with This m6A Modification: | |||||
| Epigenetic Regulation Type | RNA modification (RNAMod) >> Adenosine-to-Inosine editing (A-to-I) | ||||
| Epigenetic Regulator | Interferon-inducible protein 4 (ADAR1) | WRITER | View Details | ||
| Regulated Target | Antizyme inhibitor 1 (AZIN1) | View Details | |||
| Crosstalk Relationship | m6A → A-to-I | Enhancement | |||
| Crosstalk Mechanism | m6A modification directly impacts RNA modification through modulating the expression level of RNA modification regulator | ||||
| Crosstalk Summary | METTL3 methylates Interferon-inducible protein 4 (ADAR1) mRNA, thereby enhancing its protein expression, which subsequently promotes ADAR mediated A-to-I RNA editing of the Antizyme inhibitor 1 (AZIN1) transcript. | ||||
| Pathway Response | mRNA surveillance pathway | hsa03015 | |||
| RNA degradation | hsa03018 | ||||
| Cell Process | RNA stability | ||||
In-vitro Model |
MGG8 | Glioblastoma | Homo sapiens | CVCL_D1H4 | |
| U-87MG ATCC | Glioblastoma | Homo sapiens | CVCL_0022 | ||
| U-118MG | Astrocytoma | Homo sapiens | CVCL_0633 | ||
| H2M | Adult hepatocellular carcinoma | Homo sapiens | CVCL_M189 | ||
| NCI-H1975 | Lung adenocarcinoma | Homo sapiens | CVCL_1511 | ||
| NCI-H358 | Minimally invasive lung adenocarcinoma | Homo sapiens | CVCL_1559 | ||
| WI-38 | Normal | Homo sapiens | CVCL_0579 | ||
References
: m6A sites
: modification sites